Intersect ENT (XENT) Tops Q3 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Honeywell Aerospace starts at Hold as aftermarket exposure tempers upside outlook
• Snail, Inc. sets 1-for-5 reverse stock split to meet Nasdaq rules